• Fund Raising and/or Fund Distribution

• 190.

IRA Sohn Conference Foundation Inc

The Sohn Conference Foundation is dedicated to the treatment and cure of today’s most pressing public health priorities.

• Human Service Organizations

• 191.

Parkinson Research Foundation Inc

The Parkinson Research Foundation sponsors research, publishes scientific results, and funds education and support programs for those affected by PD.

• Birth Defects, Genetic Diseases Research

• 192.

NEW YORK STEM CELL FOUNDATION INC

The NYSCF Research Institute is a non-profit organization whose mission is to cure the major diseases of our time through stem cell research.

• Birth Defects, Genetic Diseases Research

• 193.

Sanfilippo Hope Initiative

Jarod and Caleb are brothers who suffer from an ultra-rare disease called Sanfilippo Syndrome.

• Diseases of Specific Organs

• 194.

Cure Vitiligo Inc

A teen-founded 501(c)(3) nonprofit organization dedicated to raising awareness about vitiligo and funds for a cure.

• Brain Disorders

• 195.

Global Coalition for Adaptive Research Inc

GCAR is a 501(c)(3) nonprofit organization accelerating the discovery and development of treatments for patients with rare and deadly diseases Global Coalition for Adaptive Research (GCAR) is a nonprofit organization committed to accelerating the discovery and development of treatments for patients with rare and deadly diseases Our mission is to speed the discovery and development of treatments for patients with rare and deadly diseases by serving as the sponsor of innovative trials.

Friends of FSH Research

Volunteer Run non-profit funding FSH Muscular Dystrophy research.

• Nonmonetary Support N.E.C.*

• 197.

N 1 Collaborative Inc

OUR MISSION IS TO MAKE INDIVIDUALIZED MEDICINES ROUTINELY AND RAPIDLY ACCESSIBLE TO RARE DISEASE PATIENTS WORLDWIDE.

• Alliance/Advocacy Organizations

• 198.

Nrxn1 Network

Our mission is to build a collaborative network of families, clinicians, and scientists in order to support individuals affected by NRXN1 disorder.